Sun Pharmaceutical Industries were lower at Rs. 839 on reports that the company is planning to divest a manufacturing plant in Ireland as it tries to control costs that have spiralled since it bought Ranbaxy Laboratories Ltd.
| Subscribe To Our Free Newsletter |
